Vericel Corp Ord Stock Analysis

VCEL Stock  USD 54.00  3.97  7.94%   
Vericel Corp Ord is overvalued with Real Value of 45.83 and Target Price of 41.08. The main objective of Vericel Corp stock analysis is to determine its intrinsic value, which is an estimate of what Vericel Corp Ord is worth, separate from its market price. There are two main types of Vericel Corp's stock analysis: fundamental analysis and technical analysis.
The Vericel Corp stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

Vericel Stock Analysis Notes

About 99.0% of the company outstanding shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 357.33. Vericel Corp Ord had not issued any dividends in recent years. The entity had 1:20 split on the 16th of October 2013. Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. Vericel operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 281 people. For more information please call Dominick Esq at 617 588 5555 or visit https://vcel.com.

Vericel Corp Ord Investment Alerts

The company reported the previous year's revenue of 197.52 M. Net Loss for the year was (3.18 M) with profit before overhead, payroll, taxes, and interest of 109.79 M.
Vericel Corp Ord has a poor financial position based on the latest SEC disclosures
Over 99.0% of the company outstanding shares are owned by institutional investors
Latest headline from finance.yahoo.com: Vericel Corp Q3 2024 Earnings Call Highlights Strong Revenue Growth and Strategic FDA ...

Vericel Corp Ord Upcoming and Recent Events

22nd of February 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Vericel Largest EPS Surprises

Earnings surprises can significantly impact Vericel Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-08-01
2024-06-30-0.08-0.1-0.0225 
2020-05-05
2020-03-31-0.08-0.1-0.0225 
2024-11-07
2024-09-30-0.05-0.020.0360 
View All Earnings Estimates

Vericel Corp Environmental, Social, and Governance (ESG) Scores

Vericel Corp's ESG score is a quantitative measure that evaluates Vericel Corp's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Vericel Corp's operations that may have significant financial implications and affect Vericel Corp's stock price as well as guide investors towards more socially responsible investments.

Vericel Corp Thematic Classifications

In addition to having Vericel Corp stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Pharmaceutical Products Idea
Pharmaceutical Products
USA Equities from Pharmaceutical Products industry as classified by Fama & French

Vericel Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
New York State Common Retirement Fund2024-06-30
1.1 M
Loomis, Sayles & Company Lp2024-06-30
1.1 M
Bnp Paribas Investment Partners Sa2024-06-30
M
Macquarie Group Ltd2024-06-30
M
Morgan Stanley - Brokerage Accounts2024-06-30
910.7 K
William Blair Investment Management, Llc2024-06-30
908.1 K
Federated Hermes Inc2024-06-30
840.8 K
Rtw Investments, Llc2024-06-30
801.4 K
Royal Bank Of Canada2024-06-30
762 K
Blackrock Inc2024-06-30
8.1 M
Brown Capital Management, Llc2024-06-30
4.4 M
Note, although Vericel Corp's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Vericel Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.67 B.

Vericel Profitablity

The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (0.04) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.04.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.01)(0.01)
Return On Capital Employed(0.02)(0.02)
Return On Assets(0.01)(0.01)
Return On Equity(0.01)(0.01)

Management Efficiency

The value of Return On Tangible Assets is estimated to slide to -0.0096. The value of Return On Capital Employed is expected to slide to -0.02. At this time, Vericel Corp's Intangible Assets are quite stable compared to the past year. Debt To Assets is expected to rise to 0.26 this year, although the value of Non Currrent Assets Other will most likely fall to about 732.5 K. Vericel Corp's management efficiency ratios could be used to measure how well Vericel Corp manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 4.75  4.51 
Tangible Book Value Per Share 4.60  4.37 
Enterprise Value Over EBITDA(925.74)(879.45)
Price Book Value Ratio 7.50  3.90 
Enterprise Value Multiple(925.74)(879.45)
Price Fair Value 7.50  3.90 
Enterprise Value1.6 B1.7 B
Vericel Corp Ord benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Operating Margin
(0.04)
Profit Margin
0.0156
Beta
1.667
Return On Assets
(0)
Return On Equity
0.0154

Technical Drivers

As of the 11th of November 2024, Vericel Corp has the Risk Adjusted Performance of 0.0802, semi deviation of 2.26, and Coefficient Of Variation of 1040.99. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vericel Corp Ord, as well as the relationship between them. Please validate Vericel Corp Ord jensen alpha, potential upside, as well as the relationship between the Potential Upside and skewness to decide if Vericel Corp is priced more or less accurately, providing market reflects its prevalent price of 54.0 per share. Given that Vericel Corp Ord has jensen alpha of (0.02), we advise you to double-check Vericel Corp Ord's current market performance to make sure the company can sustain itself at a future point.

Vericel Corp Ord Price Movement Analysis

Execute Study
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Vericel Corp middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Vericel Corp Ord. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Vericel Corp Ord Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vericel Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vericel Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vericel Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Colangelo Dominick over three weeks ago
Acquisition by Colangelo Dominick of 17500 shares of Vericel Corp at 3.02 subject to Rule 16b-3
 
Gilman Steven C over three weeks ago
Acquisition by Gilman Steven C of 5833 shares of Vericel Corp at 13.05 subject to Rule 16b-3
 
Jonathan Siegal over a month ago
Disposition of 568 shares by Jonathan Siegal of Vericel Corp at 41.9 subject to Rule 16b-3
 
Jonathan Siegal over a month ago
Acquisition by Jonathan Siegal of 937 shares of Vericel Corp subject to Rule 16b-3
 
Gilman Steven C over a month ago
Disposition of 5834 shares by Gilman Steven C of Vericel Corp at 45.54 subject to Rule 16b-3
 
Colangelo Dominick over a month ago
Acquisition by Colangelo Dominick of 17500 shares of Vericel Corp at 3.02 subject to Rule 16b-3
 
Colangelo Dominick over two months ago
Acquisition by Colangelo Dominick of 17500 shares of Vericel Corp at 3.02 subject to Rule 16b-3
 
Hopper Jonathan Mark over two months ago
Acquisition by Hopper Jonathan Mark of 10000 shares of Vericel Corp at 10.95 subject to Rule 16b-3
 
Rubino Alan L over two months ago
Acquisition by Rubino Alan L of 3200 shares of Vericel Corp subject to Rule 16b-3
 
Colangelo Dominick over two months ago
Acquisition by Colangelo Dominick of 17500 shares of Vericel Corp at 3.02 subject to Rule 16b-3
 
Colangelo Dominick over three months ago
Acquisition by Colangelo Dominick of 17500 shares of Vericel Corp at 3.02 subject to Rule 16b-3
 
Wotton Paul K over three months ago
Acquisition by Wotton Paul K of 3200 shares of Vericel Corp subject to Rule 16b-3

Vericel Corp Outstanding Bonds

Vericel Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Vericel Corp Ord uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Vericel bonds can be classified according to their maturity, which is the date when Vericel Corp Ord has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Vericel Corp Predictive Daily Indicators

Vericel Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Vericel Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Vericel Corp Corporate Filings

8K
7th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
21st of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
18th of October 2024
An amended filing to the original Schedule 13G
ViewVerify
F4
4th of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
2nd of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
20th of September 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
13th of September 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
5th of September 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Vericel Corp Forecast Models

Vericel Corp's time-series forecasting models are one of many Vericel Corp's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vericel Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Vericel Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Vericel Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Vericel shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Vericel Corp. By using and applying Vericel Stock analysis, traders can create a robust methodology for identifying Vericel entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.01)(0.01)
Operating Profit Margin(0.03)(0.03)
Net Loss(0.02)(0.02)
Gross Profit Margin 0.69  0.79 

Current Vericel Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Vericel analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Vericel analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
41.08Strong Buy7Odds
Vericel Corp Ord current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Vericel analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Vericel stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Vericel Corp Ord, talking to its executives and customers, or listening to Vericel conference calls.
Vericel Analyst Advice Details

Vericel Stock Analysis Indicators

Vericel Corp Ord stock analysis indicators help investors evaluate how Vericel Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Vericel Corp shares will generate the highest return on investment. By understating and applying Vericel Corp stock analysis, traders can identify Vericel Corp position entry and exit signals to maximize returns.
Begin Period Cash Flow51.1 M
Common Stock Shares Outstanding47.6 M
Total Stockholder Equity226 M
Tax Provision414 K
Quarterly Earnings Growth Y O Y1.045
Property Plant And Equipment Net115.1 M
Cash And Short Term Investments127.3 M
Cash86.9 M
Accounts Payable22.3 M
Net Debt1.3 M
50 Day M A44.2704
Total Current Liabilities45.7 M
Other Operating Expenses204 M
Non Current Assets Total148 M
Forward Price Earnings96.1538
Non Currrent Assets Other771 K
Stock Based Compensation32.3 M
When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.045
Earnings Share
0.08
Revenue Per Share
4.685
Quarterly Revenue Growth
0.27
Return On Assets
(0)
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.